表紙
市場調查報告書

異位性皮膚炎(AD)的全球市場:各治療(生物學,口服,局部,光線),終端用戶,開發平台,地區,國家(2020年版)分析:市場考察,競爭,預測(2019年∼2024年)

Global Atopic Dermatitis (AD) Market: Analysis By Therapy (Biologic, Oral, Topical, Photo), End User, Pipeline, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)

出版商 Azoth Analytics 商品編碼 923530
出版日期 內容資訊 英文 225 Pages
訂單完成後即時交付
價格
異位性皮膚炎(AD)的全球市場:各治療(生物學,口服,局部,光線),終端用戶,開發平台,地區,國家(2020年版)分析:市場考察,競爭,預測(2019年∼2024年) Global Atopic Dermatitis (AD) Market: Analysis By Therapy (Biologic, Oral, Topical, Photo), End User, Pipeline, By Region, By Country (2020 Edition): Market Insight, Competition and Forecast (2019-2024)
出版日期: 2020年01月31日內容資訊: 英文 225 Pages
簡介

全球異位性皮膚炎市場規模在2018年估算為90億9,516萬美元。污染等級的上升,全球都市化的擴大,不健康的生活方式,衛生假設支持的過敏增加等,是異位性皮膚炎的盛行率增加的要素。是濕疹最常見的形態,沒有永久的治療方法,不過,為了抑制AD相關搔癢與不適,新的治療方法導入市場。

本報告提供全球異位性皮膚炎市場相關調查分析,市場規模、佔有率、成長要素,再加上新興趨勢,主要促進因素,課題、機會,主要企業等相關的系統性資訊。

目錄

第1章 調查範圍與方法

  • 範圍
  • 調查方法
  • 摘要整理

第2章 策略性建議

  • 生物學療法的重視
  • 對發展中的經濟體的關注

第3章 產品概要

第4章 市場分析

  • 市場規模,成長率,預測(2014-2024年)

第5章 市場區隔

  • 各治療競爭方案
  • 生物學的療法-市場規模與預測(2019-2024)
  • 口服療法-市場規模及預測(2019-2024)
  • 局部療法-市場規模與預測(2019-2024)
  • 光線療法-市場規模與預測(2019-2024)

第6章 各終端用戶市場

  • 市場競爭模式:各終端用戶
  • 醫院 (2019-2024)
  • 診療所(2019-2024)
  • 研究實驗室(2019-2024)

第7章 地區分析

  • 市場競爭模式:各地區

第8章 南北美洲市場(2019-2024)

  • 市場:規模與預測(2019-2024)
  • 有名企業
  • 各療法市場(生物學,口服,局部,光線)
  • 各終端用戶(醫院,診療所,研究實驗室)市場
  • 各國分析
  • 市場機會表-各國,各金額(2024年)
  • 競爭模式:各國
  • 美國市場:規模與預測(2019-2024)
  • 美國市場:各療法,終端用戶
  • 加拿大市場:規模與預測(2019-2024)
  • 加拿大市場:各療法,終端用戶
  • 墨西哥市場:規模與預測(2019-2024
  • 墨西哥市場:各療法,終端用戶
  • 巴西市場:規模與預測(2019-2024
  • 巴西市場:各療法,終端用戶
  • 其他南北美洲市場:規模與預測(2019-2024)
  • 其他南北美洲市場:各療法,終端用戶

第9章 歐洲市場(2019-2024)

  • 市場:規模與預測(2019-2024)
  • 有名企業
  • 各療法市場(生物學,口服,局部,光線)
  • 各終端用戶(醫院,診療所,研究實驗室)市場
  • 各國分析
  • 市場機會表-各國,各金額(2024年)
  • 競爭模式:各國
  • 德國市場:規模與預測(2019-2024)
  • 德國市場:各療法,終端用戶
  • 英國市場:規模與預測(2019-2024)
  • 英國市場:各療法,終端用戶
  • 其他的歐洲市場:規模與預測(2019-2024)
  • 其他的歐洲市場:各療法,終端用戶

第10章 亞太地區市場(2019-2024)

  • 市場:規模與預測(2019-2024)
  • 有名企業
  • 各療法市場(生物學,口服,局部,光線)
  • 各終端用戶(醫院,診療所,研究實驗室)市場
  • 各國分析
  • 市場機會表-各國,各金額(2024年)
  • 競爭模式:各國
  • 日本市場:規模與預測(2019-2024)
  • 日本市場:各療法,終端用戶
  • 中國市場:規模與預測(2019-2024)
  • 中國市場:各療法,終端用戶
  • 印度市場:規模與預測(2019-2024
  • 印度市場:各療法,終端用戶
  • 澳洲市場:規模與預測(2019-2024
  • 澳洲市場:各療法,終端用戶
  • 其他的亞太地區蚊子市場:規模與預測(2019-2024)
  • 其他的亞太地區市場:各療法,終端用戶

第11章 其他地區市場(2019-2024)

  • 市場規模與預測(2019-2024)
  • 各療法市場
  • 各終端用戶市場

第12章 市場動態

  • 市場成長要素
  • 市場阻礙因素
  • 市場趨勢

第13章 市場魅力和主要趨勢

  • 市場魅力表:各療法(2024年)
  • 市場魅力表:各終端用戶(2024年)
  • 市場魅力表:各地區(2024年)
  • 主要趨勢

第14章 開發平台藥物分析

第15章 競爭情形

  • 市場佔有率分析
  • 有競爭力的定位(領導者,挑戰者,追隨者,利基企業)
  • SWOT分析
  • 波特的五力分析

第16章 公司概要(營業內容,財務分析,事業策略)

  • Sanofi
  • Regeneron
  • Pfizer
  • Allergan
  • Abbvie
  • Leo Pharma
  • Lilly
  • Aclaris Therapeutics
  • Anaptys Bio
  • Dermira
目錄

Executive Summary:

Global Atopic Dermatitis Market was valued at USD 9095.16 Million in the year 2018. Rise in pollution levels, growing urbanization, unhealthy lifestyle, increase in number of allergies backed by hygiene hypothesis are the factors leading to increasing prevalence of atopic dermatitis globally. It is the most common form of eczema, for which no permanent cure is available but novel therapies are being introduced in the market to subdue the itch and discomfort associated with AD.

Topical therapy is the highlight of the AD market, because of easy application on the skin and higher effectiveness. But with the advent of first biologic targeted therapy Dupixent in 2017 (Collaboration between Sanofi and Regeneron) in major regions of the world, AD market has experienced major revenue boost and it is expected to grow exponentially in the forecast period. Moreover Atopic Dermatitis market is also expected to grow because of elaborate pipeline by pharmaceutical companies. Also, by end user hospital may experience maximum growth as number of patient visit for AD, asthma, allergy and hay fever treatment is expected to increase during the forecast period.

Among the regions, Asia Pacific, followed by Americas and Europe will experience the highest growth rate owing to increase in prevalence as well as per capita expenditure on healthcare.

Scope of the Report:

  • The report analyses Atopic Dermatitis Market By Therapy Segment (Biologic Therapy, Topical Therapy, Oral Therapy, Photo Therapy).
  • The report assesses the Atopic Dermatitis market By End User (Hospital, Clinics, Research Labs).
  • The Global Atopic Dermatitis Market has been analysed By Region (Americas, Europe, Asia Pacific, Rest of the world) and By Country (USA, Canada, Mexico, Brazil, Germany, UK, Japan, China, India, Australia).
  • The key insights of the report have been presented through the frameworks of SWOT and Market Attractiveness charts. The attractiveness of the market has been presented by Region, Therapy and by End User. Additionally, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
  • The report provides a detailed pipeline analysis of drugs being developed to cure the problem of atopic dermatitis.
  • The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Sanofi, Regeneron, Pfizer, Allergan, Abbvie, Leo Pharma, Lilly, Aclaris, Anaptys Bio, Dermira.
  • The report presents the analysis of Atopic Dermatitis market for the historical period of 2014-2018 and the forecast period of 2019-2024.

Key Target Audience:

  • Pharmaceutical Companies
  • Consulting and Advisory Firms
  • Medical Practitioners
  • Regulatory Authorities

Table of Contents

1. Report scope & Methodology

  • 1.1 Scope of the Report
  • 1.2 Research Methodology
  • 1.3 Executive Summary

2. Strategic Recommendations

  • 2.1 Emphasis on Biologic Therapy
  • 2.2 Focus on Developing Economies

3. Global Atopic Dermatitis Market: Product Outlook

4. Global Atopic Dermatitis Market: An Analysis

  • 4.1 Market Size, Growth, Forecast (2014-2024)

5. Global Atopic Dermatitis Market Segmentation

  • 5.1 Competitive Scenario of Atopic Dermatitis: By Therapy
  • 5.2 Biologic Therapy - Market Size and Forecast (2019-2024)
  • 5.3 Oral Therapy - Market Size and Forecast (2019-2024)
  • 5.4 Topical Therapy - Market Size and Forecast (2019-2024)
  • 5.5 Phototherapy - Market Size and Forecast (2019-2024)

6. Global Atopic Dermatitis Market Segmentation By End User

  • 6.1 Competitive Scenario of Global Atopic Dermatitis: By End User
  • 6.2 Hospitals - Market Size and Forecast (2019-2024)
  • 6.3 Clinics- Market Size and Forecast (2019-2024)
  • 6.4 Research Labs - Market Size and Forecast (2019-2024)

7. Global Atopic Dermatitis Market: Regional Analysis

  • 7.1 Competitive Scenario of Global Atopic Dermatitis: By Region

8.Americas Atopic Dermatitis Market: Segmentation By Therapy, End User (2019-2024)

  • 8.1 Americas Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.2 Americas Atopic Dermatitis Market - Prominent Companies
  • 8.3 Market Segmentation By Therapy (Biologic, Oral, Topical, photo)
  • 8.4 Market Segmentation By End User (Hospitals, Clinics, Research Labs)
  • 8.5 Americas Atopic Dermatitis Market: Country Analysis
  • 8.6 Market Opportunity Chart of Americas Atopic Dermatitis Market- By Country, By Value (Year-2024)
  • 8.7 Competitive Scenario of Americas Atopic Dermatitis : Country Analysis
  • 8.8 United States Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.9 United States Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 8.10 Canada Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.11 Canada Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 8.12 Mexico Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.13 Mexico Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 8.14 Brazil Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.15 Brazil Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 8.16 Rest of Americas Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 8.17 Rest of Americas Atopic Dermatitis Market Segmentation By Therapy, End User (2019-2024)

9. Europe Atopic Dermatitis Market: Segmentation By Therapy, End User (2019-2024)

  • 9.1 Europe Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 9.2 Europe Atopic Dermatitis Market - Prominent Companies
  • 9.3 Market Segmentation By Therapy (Biologic, Oral, Topical, photo)
  • 9.4 Market Segmentation By End User (Hospitals, Clinics, Research Labs)
  • 9.5 Europe Atopic Dermatitis Market: Country Analysis
  • 9.6 Market Opportunity Chart of Europe Atopic Dermatitis Market- By Country, By Value (Year-2024)
  • 9.7 Competitive Scenario of Europe Atopic Dermatitis : Country Analysis
  • 9.8 Germany Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 9.9 Germany Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 9.10 UK Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 9.11 UK Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 9.12 Rest of Europe Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 9.13 Rest of Europe Atopic Dermatitis Market Segmentation By Therapy, End User (2019-2024)

10. Asia Pacific Atopic Dermatitis Market: Segmentation By Therapy, End User (2019-2024)

  • 10.1 Asia Pacific Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.2 Asia Pacific Atopic Dermatitis Market - Prominent Companies
  • 10.3 Market Segmentation By Therapy (Biologic, Oral, Topical, photo)
  • 10.4 Market Segmentation By End User (Hospitals, Clinics, Research Labs)
  • 10.5 Asia Pacific Atopic Dermatitis Market: Country Analysis
  • 10.6 Market Opportunity Chart of Asia Pacific Atopic Dermatitis Market- By Country, By Value (Year-2024)
  • 10.7 Competitive Scenario of Asia Pacific Atopic Dermatitis : Country Analysis
  • 10.8 Japan Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.9 Japan Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 10.10 China Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.11 China Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 10.12 India Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.13 India Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 10.14 Australia Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.15 Australia Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)
  • 10.16 Rest of Asia Pacific Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 10.17 Rest of Asia Pacific Atopic Dermatitis Market Segmentation By Therapy, End User, (2019-2024)

11. ROW Atopic Dermatitis Market: Segmentation By Therapy, End User (2019-2024)

  • 11.1 ROW Atopic Dermatitis Market: Size and Forecast (2019-2024)
  • 11.2 ROW Atopic Dermatitis Segmentation By Therapy (Biologic, Oral, Topical, photo)
  • 11.3 ROW Atopic Dermatitis Segmentation By End User (Hospitals, Clinics, Research Labs)

12. Global Atopic Dermatitis Market Dynamics

  • 12.1 Global Atopic Dermatitis Market Drivers
  • 12.2 Global Atopic Dermatitis Market Restraints
  • 12.3 Global Atopic Dermatitis Market Trends

13. Market Attractiveness and Key Developments

  • 13.1 Market Attractiveness Chart of Global Atopic Dermatitis Market - By Therapy (Year 2024)
  • 13.2 Market Attractiveness Chart of Global Atopic Dermatitis Market - By End User (Year 2024)
  • 13.3 Market Attractiveness Chart of Global Atopic Dermatitis Market - By Region (Year 2024)
  • 13.4 Key Developments in Atopic Dermatitis Market

14. Pipeline Drugs Analysis - Atopic Dermatitis

15. Competitive Landscape

  • 15.1 Market Share Analysis
  • 15.2 Competitive Positioning (Leaders, Challengers, Followers, Niche Players)
  • 15.3 SWOT Analysis
  • 15.4 Porter's Five Force Analysis

16. Company Analysis (Business Description, Financial Analysis, Business Strategy)

  • 16.1 Sanofi
  • 16.2 Regeneron
  • 16.3 Pfizer
  • 16.4 Allergan
  • 16.5 Abbvie
  • 16.6 Leo Pharma
  • 16.7 Lilly
  • 16.8 Aclaris Therapeutics
  • 16.9 Anaptys Bio
  • 16.10 Dermira

List of Figures

  • Figure 1: Global Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 2: Global Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 3: Global Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 4: Global Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 5: Total Health Spending of G7 countries (2018)(USD/Capita)
  • Figure 6: Global Market share By therapy 2018 & 2024
  • Figure 7: Global Atopic Dermatitis Market- By Biologic Therapy, By Value (USD Million), 2014-2024
  • Figure 8: Global Atopic Dermatitis Market- By Oral Therapy, By Value (USD Million), 2014-2024
  • Figure 9: Global Atopic Dermatitis Market- By Topical Therapy, By Value (USD Million), 2014-2024
  • Figure 10: Global Atopic Dermatitis Market- By Phototherapy, By Value (USD Million), 2014-2024
  • Figure 11: Global Market Share by End User 2018 & 2024
  • Figure 12: Global Atopic Dermatitis Market- By Hospital, By Value (USD Million), 2014-2024
  • Figure 13: Global Atopic Dermatitis Market- By Clinics, By Value (USD Million), 2014-2024
  • Figure 14: Global Atopic Dermatitis Market- By Research Labs, By Value (USD Million), 2014-2024
  • Figure 15: Global Market Share by Region 2018 & 2024
  • Figure 16: Americas in Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 17: Americas Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 18: Americas Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 19: Americas Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 20: Americas Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 21: Americas Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 22: Market Opportunity Chart of Americas Atopic Dermatitis Market - By Country, By Value (Year-2024)
  • Figure 23: Americas Atopic Dermatitis Market, By Country, Year 2018 & 2024
  • Figure 24: United States Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 25: US Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 26: US Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 27: US Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 28: United States GDP per Capita, 2013-2017 (USD) (In Trillion)
  • Figure 29: United States Healthcare Cost Per Capita, 2013-2017(USD)
  • Figure 30: United States Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 31: United States Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 32: Canada Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million
  • Figure 33: Canada Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 34: Canada Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 35: Canada Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 36: Canada GDP, 2013-2017 (USD) (In Trillion)
  • Figure 37: Canada Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 38: Canada Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 39: Canada Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 40: Mexico Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 41: Mexico Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 42: Mexico Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 43: Mexico Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 44: Mexico GDP, 2013-2017 (USD) (In Trillion)
  • Figure 45: Mexico Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 46: Mexico Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 47: Mexico Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 48: Brazil Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 49: Brazil Atopic Dermatitis Prevalence in age group under 5 years. (2014-2017)(%)
  • Figure 50: Brazil Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 51: Brazil Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 52: Brazil Health Spending as percent of GDP, 2013-2016 (%)
  • Figure 53: Brazil GDP , 2013-2017 (USD) (In Trillion)
  • Figure 54: Brazil Healthcare Cost Per Capita, 2013-2016(%)(Expected)
  • Figure 55: Brazil Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 56: Brazil Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 57: Rest of Americas Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 58: Rest of Americas Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 59: Rest of Americas Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 60: Europe Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 61: Europe Atopic Dermatitis Prevalence in age group under 5 years. (2014-2017)(%)
  • Figure 62: Europe Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 63: Europe Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 64: European Union current Health Expenditure (2012-2016)(% of GDP)
  • Figure 65: Europe Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 66: Europe Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 67: Market Opportunity Chart of Europe Atopic Dermatitis Market - By Country, By Value (Year-2024)
  • Figure 68: Europe Atopic Dermatitis Market, By Country, Year 2018 & 2024
  • Figure 69: Germany Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 70: Germany Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 71: Germany Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 72: Germany Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 73: Germany GDP, 2013-2017 (USD) (In Trillion)
  • Figure 74: Germany Healthcare Cost Per Capita, 2014-2018 (%)
  • Figure 75: Germany Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 76: Germany Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 77: UK Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 78: UK Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 79: UK Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 80: UK Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 81: UK GDP, 2013-2017 (USD) (In Trillion)
  • Figure 82: UK Healthcare Cost Per Capita, 2014-2018 (%)
  • Figure 83: United Kingdom Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 84: United Kingdom Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 85: Rest of Europe Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 86: Rest of Europe Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 87: Rest of Europe Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 88: Asia Pacific Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 89: Asia Atopic Dermatitis Prevalence in all age. (2014-2017)(In Million)
  • Figure 90: Asia Atopic Dermatitis Prevalence in age group 5-14 years.(2014-2017)(In Million)
  • Figure 91: Asia Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 92: East Asia and Pacific current Health Expenditure (2013-2016)(% of GDP)
  • Figure 93: Asia Pacific Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 94: Asia Pacific Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 95: Market Opportunity Chart of Asia Pacific Atopic Dermatitis Market - By Country, By Value (Year-2024)
  • Figure 96: Asia Pacific Atopic Dermatitis Market, By Country, Year 2018 & 2024
  • Figure 97: Japan Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 98: Japan Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 99: Japan Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 100: Japan Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 101: Japan GDP , 2013-2017 (USD) (In Trillion)
  • Figure 102: Japan Healthcare Cost Per Capita, 2013-2017 (%)
  • Figure 103: Japan Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 104: Japan Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 105: China Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 106: China Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(In Millions)
  • Figure 107: China Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 108: China Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 109: China GDP, 2013-2017 (USD) (In Trillion)
  • Figure 110: China Healthcare Cost Per Capita, 2013-2016 (%)
  • Figure 111: China Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 112: China Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 113: India Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 114: India Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 115: India Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 116: India Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 117: India GDP, 2013-2017 (USD) (In Trillion)
  • Figure 118: India Healthcare Cost Per Capita, 2013-2016 (%)
  • Figure 119: India Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 120: India Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 121: Australia Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 122: Australia Atopic Dermatitis Prevalence in age group 5-14 years. (2014-2017)(In Thousands)
  • Figure 123: Australia Atopic Dermatitis Prevalence in age group Under 5 years. (2014-2017)(In Thousands)
  • Figure 124: Australia Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 125: Australia Current Health Expenditure per capita (2013-2016)(current USD)
  • Figure 126: Australia Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 127: Australia Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 128: Rest of Asia Pacific Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 129: Rest of Asia Pacific Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 130: Rest of Asia Pacific Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 131: Rest of World Atopic Dermatitis Market Size, By Value, 2014-2024 (USD Million)
  • Figure 132: North Africa & Middle East AD Prevalence in age group 5-14 years. (2014-2017)(%)
  • Figure 133: North Africa & Middle East AD Prevalence in age group Under 5 years. (2014-2017)(%)
  • Figure 134: North Africa & Middle East Asthma Prevalence in all age group (2014-2017)(%)
  • Figure 135: North Africa & Middle East Current Health Expenditure per capita (2013-2016)(current USD)
  • Figure 136: Rest of World Atopic Dermatitis Market- By Therapy, By Value (USD Million), 2014-2024
  • Figure 137: Rest of World Atopic Dermatitis Market- By End User, By Value (USD Million), 2014-2024
  • Figure 138: Market Attractiveness Chart of Global Atopic Dermatitis Market - By Therapy (Year-2024)
  • Figure 139: Market Attractiveness Chart of Global Atopic Dermatitis Market - By End User(Year-2024)
  • Figure 140: Market Attractiveness Chart of Global Atopic Dermatitis Market - By Region (Year-2024)
  • Figure 141: Competitive Positions of companies dealing in Atopic Dermatitis (2018)
  • Figure 142: Sanofi, Net Sales Revenue, 2014-2018 (USD Million)
  • Figure 143: Sanofi, Net Sales by Operating Segment, 2018 (USD Million)
  • Figure 144: Sanofi, Net Sales, By Region, In 2018 (%)
  • Figure 145: Sanofi Net Income, Year 2014-2018(USD MILLION)
  • Figure 146: Regeneron, Total Revenue, 2014-2018 (USD Million)
  • Figure 147: Regeneron Net Income, Year 2014-2018 (USD MILLION)
  • Figure 148: Regeneron, Revenue Segmentation,2014-2018 (USD Million)
  • Figure 149: Pfizer, Revenue, 2014-2018 (USD Million)
  • Figure 150: Pfizer, Net Income, 2014-2018 (USD Million)
  • Figure 151: Pfizer, Revenue, By National Market, 2014-2018 (%)
  • Figure 152: Pfizer, Revenue by Segment and Geography2018 (USD Million)
  • Figure 153: Pfizer, Revenue from Eucrisa(Atopic Dermatitis) (Innovative Health), 2018 (USD Million)
  • Figure 154: Allergan, Net Revenue, 2014-2018(USD Million)
  • Figure 155: Allergan, Business Segment Revenue, 2018 (% of Total Net Revenue)
  • Figure 156: Allergan, Business Segment Revenue, 2017 (% of Total Net Revenue)
  • Figure 157: Allergan, revenue disaggregated by geography for International Segment 2018 (USD Million)
  • Figure 158: Abbvie, Net Revenue, 2014-2018 (USD Million)
  • Figure 159: Abbvie, Net Earnings, 2014-2018 (USD Million)
  • Figure 160: Abbvie, Sales by Region, 2018 (% of Total Net Revenue)
  • Figure 161: Abbvie, Sales by Region, 2017(% of Total Net Revenue)
  • Figure 162: Lilly, Revenue, 2014-2018 (USD Million)
  • Figure 163: Lilly, Net Income,(loss) 2014-2018 (USD Million)
  • Figure 164: Lilly Revenue, By Region, In 2018 (%)
  • Figure 165: Lilly Segment Revenue, 2018 (USD Million)
  • Figure 166: Aclaris Therapeutics Revenue, 2017-2018 (USD Thousands)
  • Figure 167: Aclaris Therapeutics, Gross Profit 2017-2018 (USD Thousands)
  • Figure 168: Aclaris Therapeutics Revenue by Operational segments, 2018 (USD Thousands)
  • Figure 169: Aclaris Therapeutics Revenue,(Net Loss), 2014-2018 (USD Thousands)
  • Figure 170: Anaptys Bio Revenue (Loss), 2014-2018 (USD Thousands)
  • Figure 171: Anaptys Bio, Net Income(Loss) 2014-2018 ,(USD Thousands)
  • Figure 172: Dermira Collaboration and license Revenue, 2014-2018 (USD Thousands)
  • Figure 173: Dermira, Net Income(Loss)2014-2018 ,(USD Thousands)

List of Tables

  • Table A: List Of Some FDA Approved Atopic Dermatitis Drugs
  • Table B: Topical Steroids according to potency for Atopic Dermatitis Treatment
  • Table C: Prominent Atopic Dermatitis companies operating in Americas Market
  • Table D: Prominent Atopic Dermatitis companies operating in Europe Market
  • Table E: Prominent Atopic Dermatitis companies operating in Asia Pacific Market
  • Table F: List of Injectables
  • Table G: List oF Orals
  • Table H: List of Topicals
  • Table I: Global Market Share Analysis Of Companies